Parker-Hannifin Corporation
PH
$895.24
+3.92%
Parker-Hannifin Corporation is a leading manufacturer of motion and control technologies for the industrial machinery sector. It is a diversified industrial powerhouse known for its critical components in aerospace, automation, and vehicle systems, leveraging a strategy of cross-selling integrated products.…
PH
Parker-Hannifin Corporation
$895.24
Investment Opinion: Should I buy PH Today?
Based on a synthesis of the data, the objective assessment for Parker-Hannifin (PH) is a Hold. The company demonstrates exceptional operational strength with high profitability and robust cash flow, which are hallmarks of a quality business. However, the stock's recent sharp correction and premium valuation (P/E ~25.4, PEG ~1.04) suggest limited near-term upside and elevated sensitivity to market sentiment. While the long-term thesis remains intact due to its market leadership, investors may find better entry points, or should be prepared for volatility. This rating balances strong fundamentals against current price and market conditions.
Sign up to view all
PH 12-Month Price Forecast
The assessment is neutral due to a tension between high-quality fundamentals and a full valuation post a significant run-up. The probability-weighted outlook suggests modest returns with balanced risks over the next year. Confidence is medium given the clear data on both strengths and vulnerabilities.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Parker-Hannifin Corporation's 12-month outlook, with a consensus price target around $1163.81 and implied upside of +30.0% versus the current price.
Average Target
$1163.81
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$716 - $1164
Analyst target range
Wall Street analysts maintain a generally positive view of Parker-Hannifin. Recent institutional ratings from firms like BMO Capital, Evercore ISI, Jefferies, Barclays, Wells Fargo, JP Morgan, and Citigroup are predominantly 'Buy', 'Outperform', or 'Overweight'. Consensus estimates from 5 analysts project average EPS of $42.46 and average revenue of $27.08 billion. No specific consensus target price data is provided in the inputs.
Bulls vs Bears: PH Investment Factors
Parker-Hannifin presents a mixed picture of strong fundamentals against a backdrop of market volatility and valuation concerns. Its operational excellence and cash generation are clear strengths, but the stock's recent underperformance and premium multiple introduce near-term uncertainty. The balance leans cautiously positive given the company's quality, but investor patience may be required.
Bullish
- Strong Profitability & Margins: Net margin of 17.8% and ROE of 25.8% indicate efficient operations and capital use.
- Robust Free Cash Flow: TTM FCF of $3.34B provides financial flexibility for growth and shareholder returns.
- Positive Analyst Sentiment: Major institutions maintain Buy/Outperform ratings, reflecting confidence in the business.
- Solid Revenue Growth: Q2 revenue grew 9.1% YoY, showing demand resilience in key industrial markets.
Bearish
- Recent Sharp Price Correction: Down 14.6% in one month, underperforming the SPY, indicating near-term weakness.
- Premium Valuation: Trailing P/E of 25.4 is high, requiring sustained high growth to justify.
- High Beta & Market Sensitivity: Beta of 1.22 means the stock is more volatile than the overall market.
- Economic Cycle Exposure: As an industrial, performance is tied to capital spending and economic health.
PH Technical Analysis
The stock has demonstrated significant volatility over the observed six-month period, rising from around $755 in early October 2025 to a peak above $1022 in late February 2026, before correcting sharply. Over the last month, the price has declined by 14.64%, underperforming the broader market (SPY -7.87%), indicating recent weakness. The current price of $861.48 sits approximately 16.8% below its 52-week high of $1034.96 and is 76.4% above its 52-week low of $488.45, positioning it in the upper half of its yearly range but well off recent highs.
Beta
1.22
1.22x market volatility
Max Drawdown
-22.6%
Largest decline past year
52-Week Range
$488-$1035
Price range past year
Annual Return
+47.3%
Cumulative gain past year
| Period | PH Return | S&P 500 |
|---|---|---|
| 1m | -11.3% | -5.3% |
| 3m | +1.9% | -4.6% |
| 6m | +18.1% | -2.8% |
| 1y | +47.3% | +15.9% |
| ytd | +0.1% | -4.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PH Fundamental Analysis
Revenue for the latest quarter (Q2 2026) was $5.17 billion, showing a 9.1% year-over-year growth from the prior year's comparable quarter. Profitability remains strong, with a net margin of 17.8% for the quarter, consistent with healthy operational performance. The company maintains a moderate debt-to-equity ratio of 0.70 and generates robust cash flow, with free cash flow over the trailing twelve months at $3.34 billion. Operational efficiency is solid, as evidenced by a Return on Equity (ROE) of 25.8% and a Return on Assets (ROA) of 9.4%, indicating effective use of shareholder capital and assets.
Quarterly Revenue
$5.2B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.37%
Latest Quarter
Free Cash Flow
$3.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PH Overvalued?
Given the company's positive net income, the primary valuation metric is the trailing P/E ratio, which stands at 25.38. This suggests the market is pricing the stock at a premium relative to its current earnings. A forward P/E of 25.31 and a PEG ratio of 1.04 indicate expectations for earnings growth roughly in line with the current multiple. Peer comparison data (industry averages) is not available in the provided inputs for a relative valuation check.
PE
25.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~61x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
18.2x
Enterprise Value Multiple
Investment Risk Disclosure
The primary risk for Parker-Hannifin is its cyclical exposure. As a diversified industrial, its performance is inherently linked to global capital expenditure cycles in aerospace, manufacturing, and heavy machinery. An economic slowdown or recession could rapidly dampen demand, impacting revenue growth and its ability to maintain premium valuation multiples. The stock's high beta (1.22) confirms its sensitivity to broader market movements, amplifying downside risk during market corrections. Financial risk appears moderate, with a manageable debt-to-equity ratio of 0.70 and strong free cash flow providing a buffer. However, execution risk related to integrating acquisitions and maintaining cross-selling synergies in a complex operational structure is always present. Furthermore, the lack of a significant dividend yield (0.96%) means total return is heavily dependent on price appreciation, which could be pressured if earnings growth fails to meet the high expectations embedded in its P/E ratio of over 25.
FAQ
The key risks are economic cyclicality and valuation compression. As an industrial company, PH's revenue is sensitive to global capital spending cycles. Its high beta of 1.22 means it typically falls more than the market during downturns. The primary financial risk is that its premium P/E ratio could contract if earnings growth slows, even if absolute performance remains solid. Execution risk in managing its diverse business segments is also a constant factor.
The 12-month outlook presents a range of scenarios. The base case (50% probability) sees the stock trading between $850 and $950, driven by meeting analyst EPS estimates of ~$42.46. The bull case (30%) could see a rally to $1000-$1100 on stronger growth, while the bear case (20%) risks a decline to $700-$800 on economic weakness. The consensus view from analysts is positive, but the stock's path will heavily depend on broader economic conditions.
PH appears fairly valued to slightly overvalued based on traditional metrics. Its trailing P/E of 25.4 and forward P/E of 25.3 are at a premium, which is supported by its high profitability (net margin 17.8%) but also implies high growth expectations. The PEG ratio of 1.04 suggests the stock is priced roughly in line with its expected earnings growth rate, indicating it is not significantly undervalued. Relative to its own 52-week low of $488, it is not cheap.
PH is a high-quality stock, but its attractiveness as a buy is timing-dependent. Its strong fundamentals, including a 25.8% ROE and $3.34B in annual free cash flow, make it a solid long-term holding. However, with a trailing P/E of 25.4 and a recent 14.6% monthly decline, it may be prudent for new investors to wait for stabilization or a more attractive entry point. The synthesized analyst view suggests a Hold rating at current levels.
PH is more suitable for a long-term investment horizon. Its cyclical nature and market-linked volatility (beta 1.22) make it challenging for short-term trading. Long-term investors can benefit from the company's durable competitive advantages, cash flow generation, and exposure to secular trends like automation. Short-term investors face headwinds from the stock's recent correction and full valuation, which may limit near-term upside catalysts.